Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rabies Immune Plasma Booster Program - A Clinical Study Conducted as an Investigational New Drug Study

NCT01063140 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT01063140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01063140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rabies Immune Plasma Booster Program - A Clinical Study Conducted as an Investigational New Drug Study
Lead sponsor
CSL Behring
Phase
Observational
Overall status
Completed
Start date
January 31, 2009
Completion date
May 31, 2010
Enrollment
491 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

rabies